Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Lopes RD, Alexander KP, Manoukian SV, Bertrand ME, Feit F, White HD, Pollack CV Jr, Hoekstra J, Gersh BJ, Stone GW, Ohman EM. Lopes RD, et al. Among authors: hoekstra j. J Am Coll Cardiol. 2009 Mar 24;53(12):1021-30. doi: 10.1016/j.jacc.2008.12.021. J Am Coll Cardiol. 2009. PMID: 19298914 Free article. Clinical Trial.
Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion.
Cohen M, Hoekstra J, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Pollack CV Jr, Saucedo JF. Cohen M, et al. Among authors: hoekstra j. J Interv Cardiol. 2008 Aug;21(4):283-99. doi: 10.1111/j.1540-8183.2008.00375.x. J Interv Cardiol. 2008. PMID: 18754964 Free article. Review.
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
Cohen M, Mahaffey KW, Pieper K, Pollack CV Jr, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ; SYNERGY Trial Investigators. Cohen M, et al. Among authors: hoekstra j. J Am Coll Cardiol. 2006 Oct 3;48(7):1346-54. doi: 10.1016/j.jacc.2006.05.058. Epub 2006 Sep 12. J Am Coll Cardiol. 2006. PMID: 17010793 Free article. Clinical Trial.
Bivalirudin for patients with acute coronary syndromes.
Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM; ACUITY Investigators. Stone GW, et al. Among authors: hoekstra j. N Engl J Med. 2006 Nov 23;355(21):2203-16. doi: 10.1056/NEJMoa062437. N Engl J Med. 2006. PMID: 17124018 Free article. Clinical Trial.
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).
Tricoci P, Peterson ED, Chen AY, Newby LK, Harrington RA, Greenbaum AB, Cannon CP, Gibson CM, Hoekstra JW, Pollack CV Jr, Ohman EM, Gibler WB, Roe MT. Tricoci P, et al. Am J Cardiol. 2007 May 15;99(10):1389-93. doi: 10.1016/j.amjcard.2006.12.066. Epub 2007 Mar 26. Am J Cardiol. 2007. PMID: 17493466
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
White HD, Chew DP, Hoekstra JW, Miller CD, Pollack CV Jr, Feit F, Lincoff AM, Bertrand M, Pocock S, Ware J, Ohman EM, Mehran R, Stone GW. White HD, et al. Among authors: hoekstra jw. J Am Coll Cardiol. 2008 May 6;51(18):1734-41. doi: 10.1016/j.jacc.2007.12.052. J Am Coll Cardiol. 2008. PMID: 18452778 Free article. Clinical Trial.
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.
Allen LaPointe NM, Chen AY, Roe MT, Cohen DJ, Diercks DB, Hoekstra JW, Fesmire FM, Gibler WB, Ohman EM, Peterson ED. Allen LaPointe NM, et al. Among authors: hoekstra jw. Am J Cardiol. 2009 Nov 15;104(10):1324-9. doi: 10.1016/j.amjcard.2009.06.054. Epub 2009 Sep 26. Am J Cardiol. 2009. PMID: 19892045 Free PMC article.
Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussion.
Hoekstra J, Cohen M, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Saucedo JF, Pollack CV Jr. Hoekstra J, et al. Am J Emerg Med. 2009 Jul;27(6):720-8. doi: 10.1016/j.ajem.2008.04.032. Am J Emerg Med. 2009. PMID: 19757551 Review. No abstract available.
629 results